Delivery Order SPE2DB20D1004-SPE2DB24FG3Z6

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication, to the Defense Logistics Agency (DLA). The $1,636.24 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 17, 2024, with a completion date of January 18, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,022.80 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 17, 2025, with a completion date of March 18, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML to the Defense Logistics Agency (DLA). The contract, valued at $1,187.60, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed-price pricing type and an ultimate completion date of June 24, 2024. This award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,369.16 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 21, 2024 with a completion date of March 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication, to the Defense Logistics Agency (DLA). The contract, valued at $3,745.17, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 15, 2024. The contract has a delivery order type and a firm fixed price pricing structure, with a completion date of May 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) worth up to...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,648.23 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 7, 2025, with a period of performance through March 10, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication, to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order with a firm fixed price of $1,868.60 and a completion date of June 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,425.12 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of September 20, 2024 and was awarded on September 19, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,843.52 firm fixed-price delivery order contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication product. The contract has an ultimate completion date of October 17, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 14, 2023, with a ceiling value of $1,187.60 and a completion date of June 15, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FG3Z6
    Delivery Order

This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication, to the Defense Logistics Agency (DLA). The $3,622.20 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 8, 2024 with a final completion date of July 9, 2024. This contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 and running through November 2026. The IDC allows for efficient government procurement of a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:16 AM